维普中文期刊产品整合服务
53篇 您的检索式:作者名="OGRETMEN B"
    题名 作者 年代 出处 被引量
1Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line显示文摘Ogretmen B Safa AR 2000Biochemistry2000,1139,1:1
2Role of bioactive sphingolip- ids in cancer biology and therapeutics显示文摘Saddoughi SA Song P Ogretmen B 2008Subcell Biochem2008,49,:1
3Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia显示文摘Ogretmen B Barredo JC Safa AR 2000J Pediatr Hematol Oncol2000,22,1:1
4Down-regulation of apoptosis-related bcl-2 but not BCL-xL or Bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells显示文摘Ogretmen B Safa AR 1996Int J Cancer1996,67,5:1
5Biologically active sphingolipids in cancer pathogenesis and treat -ment 显示文摘Ogretmen B Hannun Y A 2004Nat Rev Cancer2004,4,:1
6Increased expression of lung resistance-related protein and multidrug resistance-associated expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leuckemia显示文摘 Barredo JC Safa AR 2000J Pediater Hematol Oncol2000,22,1:1
7Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia 显示文摘 Barredo JC Safa AR 2000J Pediatr Hematol Oncol2000,22,1:1
8Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells显示文摘OGRETMEN B SAFA A R 1996Int J Cancer1996,67,5:1
9Biologically active sphingolipids in cancer pathogenesis and treatment显示文摘Ogretmen B Hannun Y A 2004Nat Rev Cancer2004,4,8:1
10Down regulation of apoptosis related bcl-2 but not bcl-xL or bax proteins in multidurg resistant MCF-7/Adr human breast cancer cells 显示文摘Ogretmen B Sara AR 1996Int J Cancer1996,67,5:1
11Roles of bioactive sphingolipids in cancer biology and therapeutics 显示文摘Saddoughi SA Song P Ogretmen B 2008Subcell Biochem2008,49,:1
12Biologically active sphingolipids in cancer pathogenesis and treatment显示文摘Ogretmen B Hannun Y A 2004Nat Rev Cancer2004,4,8:1
13Biologically active sphingolipids in cancer pathogenesis and treatment 显示文摘Ogretmen B Hannun YA 2004Nat Rev Cancer2004,4,8:1
14Negative regulation of MDR1 promoter activity in MCF-7,but not in multidrug resistant MCF-7/ADR, cells by Cross-coup led NF-kappa B/p65 and c-Fostranscription factors and their interaction with the CAAT region显示文摘OGRETMEN B SAFA A R 1999Biochemistry1999,38,7:1
15Biologically active sphingolipids in cancer pathogenesis and treatment 显示文摘Ogretmen B Hannun YA 2004Nat Rev Cancer2004,4,8:1
16Trace element content in marine algae species from the Black Sea, Turkey显示文摘Tuzen M Verep B Ogretmen AO Environ Monit Assess0,,:1
17Involvement of endogenous ceramide in the inhibition of telomerase activi- ty and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells 显示文摘Kraveka JM Li L Bielawski J Obeid LM Ogretmen B 2003Arch Biochem Biophys2003,419,2:1
18Negative Regulation of MDR1 Promoter Activity inMCF-7,but Not in Multidrug Resistant MCF-7/Adr,Cells by Cross-CoupledNF-κB/p65 and c-Fos Transcription Factors and Their Interaction with theCAAT Region显示文摘Ogretmen B Safa AR 1999Biochemistry1999,38,7:1
19Roles of bioactive sphingo-lipids in cancer biology and therapeutics 显示文摘Saddoughi SA Song P Ogretmen B 2008Subcell Biochem2008,49,:1
20Chapter Two-Diverse function of ceramide in cancer cell death and proliferation 显示文摘Saddoughi S A Ogretmen B 2013Advances in Cancer Research2013,117,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费